179 related articles for article (PubMed ID: 9224821)
1. High affinity binding of [3H]propionyl-[Met(O2)11]substance P(7-11), a tritiated septide-like peptide, in Chinese hamster ovary cells expressing human neurokinin-1 receptors and in rat submandibular glands.
Sagan S; Beaujouan JC; Torrens Y; Saffroy M; Chassaing G; Glowinski J; Lavielle S
Mol Pharmacol; 1997 Jul; 52(1):120-7. PubMed ID: 9224821
[TBL] [Abstract][Full Text] [Related]
2. Further evidence for the presence of "septide-sensitive" tachykinin binding sites in tissues possessing solely NK(1) tachykinin receptors.
Torrens Y; Beaujouan JC; Saffroy M; Glowinski J
Biochem Biophys Res Commun; 2000 Apr; 270(2):668-72. PubMed ID: 10753681
[TBL] [Abstract][Full Text] [Related]
3. Evidence for tachykinin NK-2 receptors in guinea-pig airways from binding and functional studies, using [125I]-[Lys5,Tyr(I2)7,MeLeu9,Nle10]-NKA(4-10).
Zeng XP; Lavielle S; Burcher E
Neuropeptides; 1994 Jan; 26(1):1-9. PubMed ID: 7512696
[TBL] [Abstract][Full Text] [Related]
4. Involvement of septide-sensitive tachykinin receptors in inositol phospholipid hydrolysis in the rat urinary bladder.
Torrens Y; Beaujouan JC; Saffroy M; Glowinski J
Peptides; 1995; 16(4):587-94. PubMed ID: 7479288
[TBL] [Abstract][Full Text] [Related]
5. Use of selective antagonists for further characterization of tachykinin NK-2, NK-1 and possible "septide-selective" receptors in guinea pig bronchus.
Zeng XP; Burcher E
J Pharmacol Exp Ther; 1994 Sep; 270(3):1295-300. PubMed ID: 7523658
[TBL] [Abstract][Full Text] [Related]
6. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
Floch A; Fardin V; Cavero I
Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
[TBL] [Abstract][Full Text] [Related]
7. Distinct regulations by septide and the neurokinin-1 tachykinin receptor agonist [pro9]substance P of the N-methyl-D-aspartate-evoked release of dopamine in striosome- and matrix-enriched areas of the rat striatum.
Gauchy C; Desban M; Glowinski J; Kemel ML
Neuroscience; 1996 Aug; 73(4):929-39. PubMed ID: 8809812
[TBL] [Abstract][Full Text] [Related]
8. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
Pradier L; Ménager J; Le Guern J; Bock MD; Heuillet E; Fardin V; Garret C; Doble A; Mayaux JF
Mol Pharmacol; 1994 Feb; 45(2):287-93. PubMed ID: 7509440
[TBL] [Abstract][Full Text] [Related]
9. Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors.
Sagan S; Chassaing G; Pradier L; Lavielle S
J Pharmacol Exp Ther; 1996 Mar; 276(3):1039-48. PubMed ID: 8786533
[TBL] [Abstract][Full Text] [Related]
10. Septide and neurokinin A are high-affinity ligands on the NK-1 receptor: evidence from homologous versus heterologous binding analysis.
Hastrup H; Schwartz TW
FEBS Lett; 1996 Dec; 399(3):264-6. PubMed ID: 8985159
[TBL] [Abstract][Full Text] [Related]
11. Internalization of [3H]substance P analogues in NK-1 receptor transfected CHO cells.
Sagan S; Lavielle S
Biochem Biophys Res Commun; 2001 Apr; 282(4):958-64. PubMed ID: 11352645
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
Ahluwalia A; Giuliani S; Maggi CA
Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of tachykinin septide-sensitive binding sites in the rat submaxillary gland.
Beaujouan JC; Saffroy M; Torrens Y; Sagan S; Glowinski J
Peptides; 1999 Nov; 20(11):1347-52. PubMed ID: 10612450
[TBL] [Abstract][Full Text] [Related]
14. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
Ciucci A; Palma C; Manzini S; Werge TM
Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
[TBL] [Abstract][Full Text] [Related]
15. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor.
Figini M; Emanueli C; Bertrand C; Javdan P; Geppetti P
Br J Pharmacol; 1996 Mar; 117(6):1270-6. PubMed ID: 8882625
[TBL] [Abstract][Full Text] [Related]
16. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
Meini S; Patacchini R; Maggi CA
Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
[TBL] [Abstract][Full Text] [Related]
17. Substance P(6-11) and natural tachykinins interact with septide-sensitive tachykinin receptors coupled to a phospholipase C in the rat urinary bladder.
Torrens Y; Saffroy M; Glowinski J; Beaujouan JC
Neuropeptides; 1997 Jun; 31(3):243-51. PubMed ID: 9243521
[TBL] [Abstract][Full Text] [Related]
18. [A new tachykinin receptor revealed by substance P analogues in the guinea pig ileum].
Petitet F; Beaujouan JC; Saffroy M; Torrens Y; Lavielle S; Chassaing G; Loeuillet D; Glowinski J
C R Acad Sci III; 1992 Mar; 314(7):299-303. PubMed ID: 1285414
[TBL] [Abstract][Full Text] [Related]
19. Binding characteristics of [125I]Bolton-Hunter [Sar9,Met(O2)11]substance P, a new selective radioligand for the NK1 receptor.
Lew R; Geraghty DP; Drapeau G; Regoli D; Burcher E
Eur J Pharmacol; 1990 Aug; 184(1):97-108. PubMed ID: 1698645
[TBL] [Abstract][Full Text] [Related]
20. Different subtypes of tachykinin NK(1) receptor binding sites are present in the rat brain.
Beaujouan JC; Saffroy M; Torrens Y; Glowinski J
J Neurochem; 2000 Sep; 75(3):1015-26. PubMed ID: 10936182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
